4/A//SEC Filing
CATALYST BIOSCIENCES, INC. 4/A
Accession 0001209191-15-085393
$GYRECIK 0001124105operating
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 5:38 PM ET
Size
5.8 KB
Accession
0001209191-15-085393
Insider Transaction Report
Form 4/AAmended
Payne Fletcher
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-10-22+28,572→ 28,572 totalExercise: $4.40Exp: 2025-10-22→ Common Stock (28,572 underlying)
Footnotes (2)
- [F1]The option grant was approved by Issuer's board of directors on October 22, 2015, subject to stockholder approval of an amendment of the Issuer's 2015 Stock Incentive Plan (the "Plan") under which the option was granted. Issuer's stockholders approved the amendment to the Plan on December 14, 2015.
- [F2]Award vests monthly over four (4) years starting September 1, 2015.
Documents
Issuer
CATALYST BIOSCIENCES, INC.
CIK 0001124105
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001124105
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 5:38 PM ET
- Size
- 5.8 KB